On Friday, April 17, a Pfizer advertisement told readers of the West Australian newspaper: “If you are taking multiple medicines for conditions such as high blood pressure or high cholesterol, there are combination options that can reduce the number of tablets you take. And the amount of money you pay.”
The advertisement had a section for [...]
-
Pages
-
Categories
- adverse events
- alcohol
- Australian Medical Association
- cancer
- child health
- childbirth and maternity services
- chronic diseases
- climate change
- Cochrane Collaboration
- complementary medicines
- conflicts of interest
- consumer health information
- Crikey register of influence
- Croakey Register of Unreleased Documents
- dental care
- e-health
- education
- environmental health
- evidence-based issues
- Federal Budget 2009-2010
- Food
- general practice
- global health
- health & medical marketing
- health and medical education
- health and medical research
- health ethics
- health financing and costs
- Health inequalities
- health reform
- health regulation
- health workforce
- Hospitals
- HRT
- illicit drugs
- Indigenous education
- Indigenous health
- infectious diseases
- influenza
- international medical graduates
- Journal articles
- legal issues
- Media-related issues
- medical education
- men's health
- mental health
- NHMRC
- NT Intervention
- nurses and nursing
- obesity
- pathology
- pharmaceutical industry
- pharmacy
- physical activity
- poverty
- prevention
- primary health care
- private health insurance
- public health
- quality and safety of health care
- rural and remote health
- screening
- surgery
- swine flu
- tests
- TGA
- tobacco control
- trauma
- Uncategorized
- weight loss products
-
Archives
